2014

Regeneron Announces Upcoming 2014 Investor Conference Presentations

TARRYTOWN, N.Y., Feb. 14, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • 2014 RBC Capital Markets' Global Healthcare Conference at 10:00 a.m. Eastern Time on Tuesday, February 25, 2014
  • Cowen and Company 34th Annual Healthcare Conference at 1:30 p.m. Eastern Time on Monday, March 3, 2014
  • Barclays Global Healthcare Conference at 1:00 p.m. Eastern Time on Tuesday, March 11, 2014

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information:




Manisha Narasimhan, Ph.D.              

Peter Dworkin

Investor Relations                                     

Corporate Communications   

914.847.5126                                              

914.847.7640             

manisha.narasimhan@regeneron.com   

peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.



RELATED LINKS
http://www.regeneron.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.